Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes
Open Access
- 1 June 2004
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 5 (1) , 13
Abstract
Elevated white blood cell counts (WBC) in acute coronary syndromes (ACS) increase the risk of recurrent events, but it is not known if this is exacerbated by pro-inflammatory factors. We sought to identify whether pro-inflammatory genetic variants contributed to alterations in WBC and C-reactive protein (CRP) in an ACS population. WBC and genotype of interleukin 6 (IL-6 G-174C) and of interleukin-1 receptor antagonist (IL1RN intronic repeat polymorphism) were investigated in 732 Caucasian patients with ACS in the OPUS-TIMI-16 trial. Samples for measurement of WBC and inflammatory factors were taken at baseline, i.e. Within 72 hours of an acute myocardial infarction or an unstable angina event. An increased white blood cell count (WBC) was associated with an increased C-reactive protein (r = 0.23, p < 0.001) and there was also a positive correlation between levels of β-fibrinogen and C-reactive protein (r = 0.42, p < 0.0001). IL1RN and IL6 genotypes had no significant impact upon WBC. The difference in median WBC between the two homozygote IL6 genotypes was 0.21/mm3 (95% CI = -0.41, 0.77), and -0.03/mm3 (95% CI = -0.55, 0.86) for IL1RN. Moreover, the composite endpoint was not significantly affected by an interaction between WBC and the IL1 (p = 0.61) or IL6 (p = 0.48) genotype. Cytokine pro-inflammatory genetic variants do not influence the increased inflammatory profile of ACS patients.Keywords
This publication has 42 references indexed in Scilit:
- The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonistsThe Pharmacogenomics Journal, 2002
- Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesisJournal of Cell Biology, 2001
- Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectorisThe American Journal of Cardiology, 2001
- The link of biocompatibility to cytokine productionKidney International, 2000
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Fibrinogen and Factor VIII, but Not Factor VII, Are Associated With Measures of Subclinical Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990